Curiosity to kill the KAT (kynurenine aminotransferase): structural insights into brain kynurenic acid synthesis

Current Opinion in Structural Biology

Volumn 18, Issue 6, 2008, Pages 748-755

  Rossi, Franca ^a   Schwarcz, Robert ^b   Rizzi, Menico ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KYNURENIC ACID; KYNURENINE AMINOTRANSFERASE;

AMINO TERMINAL SEQUENCE; BINDING SITE; CATALYSIS; CENTRAL NERVOUS SYSTEM; CONFORMATIONAL TRANSITION; CRYSTALLOGRAPHY; ENZYME ANALYSIS; HUMAN; ISOENZYME ANALYSIS; LIGAND BINDING; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW;

ANIMALS; BINDING SITES; BIOCATALYSIS; BRAIN; CENTRAL NERVOUS SYSTEM; CRYSTALLOGRAPHY; HUMANS; KYNURENIC ACID; LIGANDS; MOLECULAR STRUCTURE; TRANSAMINASES;

EID: 57049176460     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2008.09.009     Document Type: Review

References (48)

1. Moroni F. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. Eur J Pharmacol 375 (1999) 87-100
2. + homeostasis in man. Cell Mol Life Sci 61 (2004) 19-34
3. Stone T.W. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog Neurobiol 64 (2001) 185-218
4. Schwarcz R., and Pellicciari R. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303 (2002) 1-10
5. Kessler M., Terramani T., Lynch G., and Baudry M. A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists. J Neurochem 52 (1989) 1319-1328
6. Birch P.J., Grossman C.J., and Hayes A.G. Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor. Eur J Pharmacol 154 (1988) 85-87
7. Pereira E.F., Hilmas C., Santos M.D., Alkondon M., Maelicke A., and Albuquerque E.X. Unconventional ligands and modulators of nicotinic receptors. J Neurobiol 53 (2002) 479-500
8. Hilmas C., Pereira E.F., Alkondon M., Rassoulpour A., Schwarcz R., and Albuquerque E.X. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 21 (2001) 7463-7473
9. Wang J., Simonavicius N., Wu X., Swaminath G., Reagan J., Tian H., and Ling L. Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 281 (2006) 22021-22028
10. Ohshiro H., Tonai-Kachi H., and Ichikawa K. GPR35 is a functional receptor in rat dorsal root ganglion neurons. Biochem Biophys Res Comm 365 (2008) 344-348
11. Carpenedo R., Pittaluga A., Cozzi A., Attucci S., Galli A., Raiteri M., and Moroni F. Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci 13 (2001) 2141-2147
12. Wu H.-Q., Rassoulpour A., and Schwarcz R. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?. J Neural Transm 114 (2007) 33-41. This study describes the bidirectional regulation of extracellular dopamine by fluctuating brain KYNA levels, strengthening the idea that drugs targeting brain KYNA synthesis may be of use in the treatment of severe brain disorders.
13. Wu H.-Q., Potter M.C., Rassoulpour A., Albuquerque E.X., and Schwarcz R. Nanomolar kynurenic acid decreases extracellular acetylcholine levels in the rat striatum. Soc Neurosci Abstr 30 (2004) 950-954
14. Schwarcz R., Rassoulpour A., Wu H.-Q., Medoff D., Tamminga C.A., and Roberts R.C. Increased cortical kynurenate content in schizophrenia. Biol Psychiatry 50 (2001) 521-530
15. Nilsson L.K., Linderholm K.R., Engberg G., Paulson L., Blennow K., Lindström L.H., Nordin C., Karanti A., Persson P., and Erhardt S. Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia. Schizophr Res 80 (2005) 315-322
16. Baran H., Jellinger K., and Deecke L. Kynurenine metabolism in Alzheimer's disease. J Neural Transm 106 (1999) 165-181
17. Erhardt S., Schwieler L., Nilsson L., Linderholm K., and Engberg G. The kynurenic acid hypothesis of schizophrenia. Physiol Behav 92 (2007) 203-209. This study further highlights the role of KYNA in the pathogenesis of schizophrenia and supports the emerging idea of targeting KATs for the development of novel antipsychotic drugs.
18. Chess A.C., and Bucci D.J. Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding. Behav Brain Res 170 (2006) 326-332
19. Eliot A.C., and Kirsch J.F. Pyridoxal phosphate enzymes: mechanistic, structural, and evolutionary considerations. Annu Rev Biochem 73 (2004) 383-415
20. Jansonius J.N. Structure, evolution and action of vitamin B6-dependent enzymes. Curr Opin Struct Biol 8 (1998) 759-769
21. Okuno E., Nakamura M., and Schwarcz R. Two kynurenine aminotransferases in human brain. Brain Res 542 (1991) 307-312
22. Okuno E., Schmidt W., Parks D.A., Nakamura M., and Schwarcz R. Measurement of rat brain kynurenine aminotransferase at physiological kynurenine concentrations. J Neurochem 57 (1991) 533-540
23. Buchli R., Alberati-Giani D., Malherbe P., Köhler C., Broger C., and Cesura A.M. Cloning and functional expression of a soluble form of kynurenine/alpha-aminoadipate aminotransferase from rat kidney. J Biol Chem 270 (1995) 29330-29335
24. Guidetti P., Amori L., Sapko M.T., Okuno E., and Schwarcz R. Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain. J Neurochem 102 (2007) 103-111
25. Yu P., Li Z., Zhang L., Tagle D.A., and Cai T. Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family. Gene 365 (2006) 111-118
26. Han Q., Li J., and Li J. pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I. Eur J Biochem 271 (2004) 4804-4814
27. Cooper A.J., and Pinto J.T. Cysteine S-conjugate beta-lyases. Amino Acids 30 (2006) 1-15
28. Cooper A.J., Pinto J.T., Krasnikov B.F., Niatsetskaya Z.V., Han Q., Li J., Vauzour D., and Spencer J.P. Substrate specificity of human glutamine transaminase K as an aminotransferase and as a cysteine S-conjugate beta-lyase. Arch Biochem Biophys 474 (2008) 72-81
29. Cooper A.J. The role of glutamine transaminase K (GTK) in sulfur and alpha-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants. Neurochem Int 44 (2004) 557-577
30. Guidetti P., Okuno E., and Schwarcz R. Characterization of rat brain kynurenine aminotransferases I and II. J Neurosci Res 50 (1997) 457-465
31. Rossi F., Han Q., Li J., Li J., and Rizzi M. Crystal structure of human kynurenine aminotransferase I. J Biol Chem 279 (2004) 50214-50220
32. Rossi F., Garavaglia S., Montalbano V., Walsh M.A., and Rizzi M. Crystal structure of human kynurenine aminotransferase II, a drug target for the treatment of schizophrenia. J Biol Chem 283 (2008) 3559-3566. This paper describes the first crystal structure of human KAT II in its PLP form and suggests how the design of isozyme-specific inhibitors can be achieved.
33. Han Q., Robinson H., and Li J. Crystal structure of human kynurenine aminotransferase II. J Biol Chem 283 (2008) 3567-3573. This paper reports the first crystal structure of human KAT II in complex with kynurenine, thus revealing the essential molecular determinants for ligand recognition.
34. Han Q., Gao Y.G., Robinson H., Ding H., Wilson S., and Li J. Crystal structures of Aedes aegypti kynurenine aminotransferase. FEBS J 272 (2005) 2198-2206
35. Wogulis M., Chew E.R., Donohoue P.D., and Wilson D.K. Identification of formyl kynurenine formamidase and kynurenine aminotransferase from Saccharomyces cerevisiae using crystallographic, bioinformatic and biochemical evidence. Biochemistry 47 (2008) 1608-1621. The study identifies a yeast KAT by the combined use of crystallographic and biochemical methods and reinforces the notion of a role of the N-terminal region in catalysis.
36. Chon H., Matsumura H., Koga Y., Takano K., and Kanaya S. Crystal structure of a human kynurenine aminotransferase II homologue from Pyrococcus horikoshii OT3 at 2.20 Å resolution. Proteins 61 (2005) 685-688
37. Rossi F., Garavaglia S., Giovenzana G.B., Arcà B., Li J., and Rizzi M. Crystal structure of the Anopheles gambiae 3-hydroxykynurenine transaminase. Proc Natl Acad Sci U S A 103 (2006) 5711-5716
38. Christen P., and Mehta P.K. From cofactor to enzymes. The molecular evolution of pyridoxal-5′-phosphate-dependent enzymes. Chem Rec 1 (2001) 436-447
39. Percudani R., and Peracchi A. A genomic overview of pyridoxal-phosphate-dependent enzyme. EMBO Rep 4 (2003) 850-854
40. Clausen T., Huber R., Laber B., Pohlenz H.D., and Messerschmidt A. Crystal structure of the pyridoxal-5′-phosphate dependent cystathionine beta-lyase from Escherichia coli at 1.83 Å. J Mol Biol 262 (1996) 202-224
41. Zhang X., Roe S.M., Hou Y., Bartlam M., Rao Z., Pearl L.H., and Danpure C.J. Crystal structure of alanine:glyoxylate aminotransferase and the relationship between genotype and enzymatic phenotype in primary hyperoxaluria type 1. J Mol Biol 331 (2003) 643-652
42. Kwok J.B., Kapoor R., Gotoda T., Iwamoto Y., Iizuka Y., Yamada N., Isaacs K.E., Kushwaha V.V., Church W.B., Schofield P.R., and Kapoor V. A missense mutation in kynurenine aminotransferase-1 in spontaneously hypertensive rats. J Biol Chem 277 (2002) 35779-35782
43. Jensen R.A., and Gu W. Evolutionary recruitment of biochemically specialized subdivisions of Family I within the protein superfamily of aminotransferases. J Bacteriol 178 (1996) 2161-2171
44. Han Q., Gao Y.G., Robinson H., and Li J. Structural insight into the mechanism of substrate specificity of Aedes kynurenine aminotransferase. Biochemistry 47 (2008) 1622-1630. This paper describes the crystal structure of mosquito KAT I in the form of external aldimine complexes with glutamine and cysteine and contributes significantly to the understanding of substrate recognition and specificity in KAT I.
45. Han Q., Cai T., Tagle D.A., Robinson H., and Li J. Substrate specificity and structure of human aminoadipate aminotransferase/kynurenine aminotransferase II. Biosci Rep 28 (2008) 205-215
46. Pellicciari R., Rizzo R.C., Costantino G., Marinozzi M., Amori L., Guidetti P., Wu H.Q., and Schwarcz R. Modulators of the kynurenine pathway of tryptophan metabolism: synthesis and preliminary biological evaluation of (S)-4-(ethylsulfonyl)benzoylalanine, a potent and selective kynurenine aminotransferase II (KAT II) inhibitor. ChemMedChem 1 (2006) 528-531
47. Amadasi A., Bertoldi M., Contestabile R., Bettati S., Cellini B., di Salvo M.L., Borri-Voltattorni C., Bossa F., and Mozzarelli A. Pyridoxal 5′-phosphate enzymes as targets for therapeutic agents. Curr Med Chem 14 (2007) 1291-1324
48. DeLano W.L. The PyMOL Molecular Graphics System (2002), DeLano Scientific, Palo Alto, CA, USA